Patrick John Stover

age ~59

from College Station, TX

Get Report

Also known as:

Patrick J Stover
Patrick J Stver
Pat Stover

Phone and address:: 3145 Chaco Canyon Dr, College Station, TX 77845

Connected to:

Patrick Stover Phones & Addresses

3145 Chaco Canyon Dr, College Sta, TX 77845
College Station, TX
Fort Worth, TX
205 Comstock Rd, Ithaca, NY 14850 • 6072579781 • 6072669486
Hayward, CA
Marcus Hook, PA
Albany, CA
Richmond, VA
205 Comstock Rd, Ithaca, NY 14850 • 6072579781

Work

Position:

Homemaker

Education

Degree:

Graduate or professional degree

Resumes

Vice Chancellor And Dean

view source

Location:

3145 Chaco Canyon Dr, College Station, TX 77845

Industry:

Higher Education

Work:

Texas A&M University System
Vice Chancellor and Dean
Cornell University Jul 1994 - Feb 2018
College of Human Ecology, Professor, Division Director
Annual Reviews Jul 1994 - Feb 2018
Co-Editor of Annual Reviews of Nutrition
American Society For Nutrition Jul 1994 - Feb 2018
Past President
Uc Berkeley 1991 - 1994
Post-Doctoral Associate

Education:

Medical College of Virginia 1987 - 1991
Doctorates, Doctor of Philosophy, Biochemistry, Philosophy, Molecular Biophysics Saint Joseph's University 1983 - 1987
Bachelors, Bachelor of Science, Chemistry

Skills:

Nutrition
Genomics
Cell Biology
Science
Public Health
Lifesciences
Physiology
Metabolism
Biochemistry
Epidemiology
Microbiology
Animal Models
Translational Research
Genetics
Life Sciences
Biostatistics
Systems Biology
Higher Education
Cell Culture
Protein Chemistry
In Vitro
Microscopy
Qpcr
Pcr
Western Blotting
Vitamins
Neuroscience
Academic Administration
Folate

Interests:

Nutrition
Metabolism
Systems Biology
Genomics

Patrick Stover

view source

Patrick Stover

view source

Patrick Stover

view source

Patrick Stover

view source

Patrick Stover

view source

Location:

United States

Patrick Stover

view source

Location:

United States

Us Patents

Treatment Or Prevention Of Cancer Or Cardiovascular Disease With Methenyltetrahydrofolate Synthetases
view source
US Patent:

20090005385, Jan 1, 2009
Filed:

Jun 13, 2005
Appl. No.:

11/571213
Inventors:

Patrick J. Stover - Ithaca NY, US
Assignee:

CORNELL RESEARCH FOUNDATION, INC. - Ithaca NY
International Classification:

A61K 31/495
C12Q 1/02
A61P 31/00
US Classification:

514249, 435 29
Abstract:

The present invention relates to a method of screening test substances for chemotherapeutic activity or for efficacy in treating cardiovascular disease by providing one or more cells transformed with a nucleic acid molecule encoding methenyltetrahydrofolate synthetase, contacting the cells with test substance(s), and identifying those test substances which modulate methenyltetrahydrofolate synthetase expression as candidates for such therapeutic use. Another aspect of the present invention relates to a method of measuring folate status in a sample by measuring methenyltetrahydrofolate synthetase expression or activity and/or catecholamine activity in the sample, all of which are correlated to folate status in the sample. The present invention can also be used to treat or prevent cancer or cardiovascular disease in a subject by administering to the subject a substance which modulates methenyltetrahydrofolate synthetase expression or activity and/or catecholamine activity.

Use Of Uridine And Deoxyuridine To Treat Folate-Responsive Pathologies
view source
US Patent:

20140080784, Mar 20, 2014
Filed:

Apr 25, 2012
Appl. No.:

14/113858
Inventors:

Patrick J. Stover - Ithaca NY, US
Martha S. Field - Burdett NY, US
Assignee:

CORNELL UNIVERSITY - Ithaca NY
International Classification:

A61K 31/7072
A61N 5/10
A23L 1/30
A61K 45/06
US Classification:

514 50, 600 1
Abstract:

The present invention relates to a pharmaceutical or dietary composition comprising deoxyuridine and a pharmaceutically or dietetically suitable carrier. Another aspect of the present invention relates to a method of supplementing the dietary needs of a subject. This method includes administering to the subject a dietary supplementing effective amount of deoxyuridine. Yet another aspect of the present invention relates to a method of treating cancer in a subject. This method includes selecting a subject having cancer and administering to the selected subject a therapeutically effective amount of uridine, thereby treating the cancer in the selected subject.